Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis.
Autorino R, Tagliaferri L, Campitelli M, Smaniotto D, Nardangeli A, Mattiucci GC, Macchia G, Gui B, Miccò M, Mascilini F, Ferrandina G, Kovacs G, Valentini V, Gambacorta MA. Autorino R, et al. Among authors: campitelli m. J Contemp Brachytherapy. 2018 Aug;10(4):315-320. doi: 10.5114/jcb.2018.77953. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237815 Free PMC article.
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study.
Rufini V, Collarino A, Calcagni ML, Meduri GM, Fuoco V, Pasciuto T, Testa AC, Ferrandina G, Gambacorta MA, Campitelli M, Gui B, Zannoni G, Manfredi R, Scambia G, Giordano A. Rufini V, et al. Among authors: campitelli m. Eur J Nucl Med Mol Imaging. 2020 May;47(5):1228-1238. doi: 10.1007/s00259-019-04436-y. Epub 2019 Aug 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31414206
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
Macchia G, Nardangeli A, Laliscia C, Fodor A, Draghini L, Gentile PC, D'Agostino GR, Balcet V, Bonome P, Ferioli M, Autorino R, Vicenzi L, Raguso A, Borghesi S, Ippolito E, Di Cataldo V, Cilla S, Perrucci E, Campitelli M, Gambacorta MA, Deodato F, Scambia G, Ferrandina G. Macchia G, et al. Among authors: campitelli m. Int J Gynecol Cancer. 2022 Jun 6;32(6):732-739. doi: 10.1136/ijgc-2021-003237. Int J Gynecol Cancer. 2022. PMID: 35193941
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R, Gui B, Panza G, Boldrini L, Cusumano D, Russo L, Nardangeli A, Persiani S, Campitelli M, Ferrandina G, Macchia G, Valentini V, Gambacorta MA, Manfredi R. Autorino R, et al. Among authors: campitelli m. Radiol Med. 2022 May;127(5):498-506. doi: 10.1007/s11547-022-01482-9. Epub 2022 Mar 24. Radiol Med. 2022. PMID: 35325372 Free PMC article. Review.
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images.
Cusumano D, Russo L, Gui B, Autorino R, Boldrini L, D'Erme L, Persiani S, Catucci F, Broggi S, Panza G, Nardangeli A, Campitelli M, Ferrandina G, Macchia G, Fiorino C, Valentini V, Scambia G, Manfredi R, Gambacorta MA. Cusumano D, et al. Among authors: campitelli m. Radiother Oncol. 2022 Sep;174:30-36. doi: 10.1016/j.radonc.2022.07.001. Epub 2022 Jul 8. Radiother Oncol. 2022. PMID: 35811004
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group Groups.
Macchia G, Pezzulla D, Campitelli M, Laliscia C, Fodor A, Bonome P, Draghini L, Ippolito E, De Sanctis V, Ferioli M, Titone F, Balcet V, Di Cataldo V, Russo D, Vicenzi L, Cossa S, Lucci S, Cilla S, Deodato F, Gambacorta MA, Scambia G, Morganti AG, Ferrandina G. Macchia G, et al. Among authors: campitelli m. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):321-332. doi: 10.1016/j.ijrobp.2023.04.025. Epub 2023 May 6. Int J Radiat Oncol Biol Phys. 2023. PMID: 37150261
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates.
Lancellotta V, Macchia G, Dinapoli N, Autorino R, Campitelli M, Nardangeli A, Salvati A, Fionda B, Casà C, Cornacchione P, Rovirosa A, Kovács G, Morganti AG, Ferrandina MG, Gambacorta MA, Tagliaferri L. Lancellotta V, et al. Among authors: campitelli m. Radiol Med. 2022 Mar;127(3):341-348. doi: 10.1007/s11547-022-01455-y. Epub 2022 Jan 29. Radiol Med. 2022. PMID: 35092552 Free PMC article.
150 results